EY | Research | Pharma & Life Sciences

An overview of EY research in Europe in the Pharma & Life Sciences industry:

M&A deals in life sciences sector to rebound in 2023, says EY 2022 was a slow year for dealmaking in the global life sciences industry.
17 January 2023

More EY news

‘China to curb power of Big Four accountants and consultants’ China's government is trying to curb the power of the Big Four, especially in the audit domain, according to reports from Bloomberg citing discussions with high-ranked partners within the Chinese org
07 March 2023
EY announces cost-cutting cull of 400 German staff The German member firm of EY is set to offload over 400 partners and staff, as the Big Four firm looks to steady its finances, after it took a major reputational knock from its involvement in the Wir
27 February 2023
Hiring and retaining talent remains top priority for private equity Despite the cooling of the M&A industry, private equity firms continue to place talent management at the top of their list of strategic priorities for 2023, right behind asset growth.
31 January 2023
The most attractive markets for renewable energy investment Since 2003, professional services firm EY has ranked the world’s top 40 markets on the attractiveness of their renewable energy investment and deployment opportunities.
08 January 2023

1

1 found

About Consultancy.eu

Consultancy.org network

Consultancy.org network